Skip to main content
INBIOGEN Co., Ltd. (KRX:101140)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,570.00
+310.00 (3.75%)
At close: Apr 29, 2026

INBIOGEN Revenue

In the year 2025, INBIOGEN had annual revenue of 6.30B KRW, down -10.57%. INBIOGEN had revenue of 660.60M in the quarter ending December 31, 2025, a decrease of -69.52%.

Revenue
6.30B
Revenue Growth
-10.57%
P/S Ratio
13.10
Revenue / Employee
153.58M
Employees
41
Market Cap
82.47B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20256.30B-744.31M-10.57%
Dec 31, 20247.04B800.26M12.82%
Dec 31, 20236.24B-4.18B-40.10%
Dec 31, 202210.42B-61.30M-0.58%
Dec 31, 202110.48B263.11M2.58%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Nature Holdings 477.52B
Uni-Chem 106.24B
09WOMEN 45.04B
SYTS Corp. 174.69B
HWASEUNG Industries 1,781.04B
BAIKSAN Co,. 504.92B
Au Brandz Co.,Ltd 60.01B
Hwaseung Enterprise 1,564.38B
Revenue Rankings

INBIOGEN News

More News